COMMONWEALTH EQUITY SERVICES, LLC
Position in AQST — Aquestive Therapeutics, Inc.
CIK 312272
WALTHAM, MA
Position in AQST
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$4,352,088
-$141,034 QoQ
Shares Held
1,046,175
-3.4% QoQ
Ownership
0.834%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#17
of 184 holders
Holding Since
Sep 2025
4 quarters on record
Common Shares in AQST Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026COMMONWEALTH EQUITY SERVICES, LLC holds $49,855,783 across 32 Drug Manufacturers - Specialty & Generic names. AQST ranks #4 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
171,031 | $12,290,287 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
337,688 | $11,707,642 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
131,451 | $4,453,559 | |
| 4 | AQST |
Aquestive Therapeutics, Inc.
This page
|
1,046,175 | $4,352,088 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
5,205 | $2,820,225 | |
| 6 | VTRS |
Viatris Inc
|
174,057 | $2,764,025 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
15,270 | $2,573,605 | |
| 8 | HLN |
Haleon plc
|
195,825 | $1,827,047 |
All Filings in AQST
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,352,088 | 1,046,175 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $4,493,122 | 1,082,680 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $6,587,856 | 1,019,792 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,918,272 | 1,058,725 | Shares | Sole | 2025-10-22 | |
| No filing history on record for this holder in this stock. | ||||||